Clinical TrialsSearch results
Number of results: 2568
Other
- Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer
- Non-small cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
- Breast Cancer
- Office for cordination of Herceptin trial
- 2007-03-23
Other
- Randomized phase II study of irinotecan and cisplatin or irinotecan, cisplatin and etoposide in patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer
- Division of Medical Oncology, National Cancer Center Hospital
- 2006-06-01
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
- biliary tract neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2009-02-04
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine in advanced biliary tract cancer (GS-COMBI).
- Advanced biliary tract cancer
- Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)
- 2009-02-12
Other
- Randomized phase II study of docetaxel plus zoledronic acid versus docetaxel in patients with relapsing or refractory non-small cell lung cancer and bone metastasis
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-03-26
Other
- Randomized Phase II Study of Docetaxel (T) with or without Capecitabine (X) as Neoadjuvant Chemotherapy in Female Patients with Operable Breast Cancer Who were not Observed Disease Progression after 4 cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) (OOTR N003)
- Operable breast cancer
- Organization for Oncology and Translational Research (OOTR)
- 2006-02-10
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08
Other
- Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancer
- Advanced bile duct cancer
- Osaka International Cancer Institute Department of Hepatobiliary and pancreatic Oncology
- 2008-12-22